Results 291 to 300 of about 589,499 (392)

Feedback inhibition of dopamine synthesis by continuous administration of dopamine agonists

, 2000
Shin-ichi Iwata, Masahiro Nomoto, Shun Kaseda, Takeo Fududa   +3 more
openalex   +1 more source

Patient Participation in Urine Specific Gravity Screening for Arginine Vasopressin Deficiency in an Inpatient Neurosurgical Clinic

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Detecting hypotonic urine (specific gravity < 1005 g/L) is crucial for the early identification of arginine vasopressin deficiency (AVP‐deficiency), a common complication after pituitary surgery. This study aimed to evaluate the agreement between urine specific gravity measurements taken by patients using urine test strips and those ...
Jeanne‐Marie Nollen, Anja H. Brunsveld‐Reinders, Nienke R. Biermasz, Marco J. T. Verstegen, Eline Leijtens, Wilco C. Peul, Ewout W. Steyerberg, Wouter R. van Furth   +7 more
wiley   +1 more source

Dihydrexidine — The First Full Dopamine D₁ Receptor Agonist [PDF]

, 2004
Peter Salmi, Ruben Isacson, Björn Kull
openalex   +1 more source

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.

JAMA Neurol, 2022
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE, PD MED Collaborative Group.   +12 more
europepmc   +1 more source

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre survey. [PDF]

J Neural Transm (Vienna), 2020
Rizos A, Sauerbier A, Falup-Pecurariu C, Odin P, Antonini A, Martinez-Martin P, Kessel B, Henriksen T, Silverdale M, Durner G, Ray Chaudhuri K, EUROPAR and the IPMDS Non-Motor PD Study Group.   +11 more
europepmc   +1 more source

Expanding the Phenotypic Spectrum of SPG7 Rare Damaging Variants: Insights From a Hungarian Cohort

Clinical Genetics, EarlyView.
Rare damaging SPG7 variants were detected in 58 patients with spastic paraplegia, ataxia, mitochondrial dysfunction, or motoneuron lesions. The cumulative prevalence of SPG7‐related conditions in Hungary was estimated. Phenotypic spectra and mitochondrial dysfunction were assessed in monoallelic and biallelic cases, contributing to the understanding of
Idris Janos Jimoh, Peter Balicza, Tamas Szlepak, Dora Csaban, Aniko Gal, Adrienn Geresi, Zoltan Grosz, Agnes Palasti, Judit Boczan, Peter Klivenyi, Maria Judit Molnar   +10 more
wiley   +1 more source

Kappa Counterconditioning of Cocaine Cues [PDF]

, 2018
Mantsch, John R., Twining, Robert C.
core   +1 more source

Adrogolide HCl (ABT‐431; DAS‐431), a Prodrug of the Dopamine D₁ Receptor Agonist, A‐86929: Preclinical Pharmacology and Clinical Data

, 2001
William J. Giardina, Michael Williams
openalex   +1 more source

The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases

Cell Proliferation, EarlyView.
Polymeric nanoparticles represent promising drug (gene) delivery carriers to the brain due to their unique advantages to facilitate the penetration of blood–brain barrier and endocytosis of neuronal cells in neurodegenerative diseases. ABSTRACT In spite of great advances in modern medicine, there are a few effective strategies for the treatment of ...
Lian Jin, Libo Nie, Yan Deng, Ghulam Jilany Khana, Nongyue He   +4 more
wiley   +1 more source

Non-ergot dopamine agonists and heart failure. [PDF]

Anatol J Cardiol, 2019
Şener YZ, Okşul M, Çöteli C.
europepmc   +1 more source